Arcellx, Inc.
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical tr…
Biotechnology
US, Gaithersburg [HQ]
Cash Flow Statements
5 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow (OCF) | -18.00 | -28.00 | -54.00 | -99.00 | 207.00 | |
| Operating Cash (Net) | -18.00 | -28.00 | -54.00 | -99.00 | 207.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | -1.00 | - - | 7.00 | -6.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | |
| Change | -1.00 | 1.00 | 2.00 | 4.00 | 225.00 | |
| Other WC | -1.00 | 3.00 | 1.00 | -2.00 | 231.00 | |
| Investing Activities | ||||||
| Used Cash (Net) | -3.00 | - - | -79.00 | -117.00 | -154.00 | |
| Capital Expenditure | -3.00 | - - | -5.00 | -2.00 | -21.00 | |
| Purchases of Investments | - - | - - | -74.00 | -273.00 | -442.00 | |
| Sale/Maturity of Investment | - - | - - | - - | 158.00 | 309.00 | |
| Property, Plant, Equipment (P&PE) | -3.00 | - - | -5.00 | -2.00 | -21.00 | |
| Acquisitions (Net) | - - | - - | - - | 115.00 | 133.00 | |
| Other Investing Activities | - - | - - | -74.00 | -115.00 | -133.00 | |
| Financing Activities | ||||||
| Used Cash (Net) | -42.00 | -41.00 | -118.00 | -252.00 | -279.00 | |
| Debt Repayment | - - | - - | - - | -9.00 | -29.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | 119 | - - | 307 | |
| Issued | 42.00 | 41.00 | 119.00 | 259.00 | 308.00 | |
| Repurchased | - - | - - | - - | - - | 1.00 | |
| Other Financing Activities | 42.00 | -1.00 | 118.00 | 2.00 | 308.00 | |
| Cash Balances | ||||||
| Begin of Period | 14.00 | 34.00 | 46.00 | 31.00 | 64.00 | |
| End of Period | 34.00 | 46.00 | 31.00 | 66.00 | 396.00 | |
| Change | 20.00 | 12.00 | -15.00 | 35.00 | 332.00 | |
| Non-Cash Balances | ||||||
| Depreciation and Amortization | - - | - - | 1.00 | 1.00 | 2.00 | |
| Stock Based Compensation | - - | 1.00 | 6.00 | 21.00 | 41.00 | |
| Other | - - | 3.00 | - - | 62.00 | 2.00 | |
| Highlighted metrics | ||||||
| Free Cash Flow (FCF) | -22.00 | -29.00 | -60.00 | -101.00 | 186.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | -468.00 | |
| Invested Capital | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - |